<Disease><Name>HYPEREKPLEXIA</Name><Synonym>STARTLE DISEASE; KOK-DISEASE</Synonym><OMIM><Number>149400</Number><URL>http://omim.org/entry/149400</URL></OMIM><Orphanet><Number>3197</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=3197</URL></Orphanet><Protein><Number>glycine receptor subunit alpha-1</Number><URL>http://www.uniprot.org/uniprot/P23415</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>5q33.1</Gene><ICD>G25.88</ICD><Summary>rare ;autosomal dominant;autosomal recessive;mutation in the GLRA1 gene</Summary><Symptoms><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2256</id><symptom>EMG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3358</id><symptom>exaggerated startle reflex</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2428</id><symptom>hernia</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>2066</id><symptom>metabolic alkalosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3430</id><symptom>muscle stiffness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1704</id><symptom>sudden death</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>4630</id><title>The impact of human hyperekplexia mutations on glycine receptor structure and function</title><author>Bode A,</author><journal>Mol Brain</journal><year>2014</year><book /><volume>7</volume><number>0</number><pages>2</pages><co_aut>Lynch JW</co_aut></literature><literature><id>4631</id><title>Hyperekplexia</title><author>Tijssen MAJ,</author><journal>GeneReviews&#174; [Internet]</journal><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Rees MI</co_aut></literature><literature><id>2634</id><title>Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia</title><author>Eulenburg V</author><journal>Biochem Biophys Res Commun</journal><year>2006</year><book /><volume>348</volume><number>0</number><pages>400-405</pages><co_aut>et al.</co_aut></literature><literature><id>2635</id><title>Hyperekplexia in Kurdish families: a possible GLRA1 founder mutation</title><author>Siren A</author><journal>Neurology</journal><year>2006</year><book /><volume>67</volume><number>11</number><pages>137-139</pages><co_aut>et al.</co_aut></literature><literature><id>2636</id><title>Startle syndromes</title><author>Bakker MJ</author><journal>Lancet Neurol</journal><year>2006</year><book /><volume>5</volume><number>0</number><pages>513-524</pages><co_aut>et al.</co_aut></literature><literature><id>2637</id><title>Severe normotensive metabolic alkalosis in a 2-month-old boy with hyperekplexia</title><author>Schlapbach LJ</author><journal>J Inher Met Dis</journal><year>2006</year><book /><volume>29</volume><number>0</number><pages>238-239</pages><co_aut>et al.</co_aut></literature><literature><id>1426</id><title>Hyperekplexia (startle disease): a novel mutation (S270T) in the M2 domain of the GLRA1 gene and a molecular review of the diso</title><author>Lapunzina P</author><journal>Mol Diagn</journal><year>2003</year><book /><volume>7</volume><number>2</number><pages>125-128</pages><co_aut>et al.</co_aut></literature><literature><id>1425</id><title>Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLR</title><author>Rees MI</author><journal>Hum Mol Genet</journal><year>2002</year><book /><volume>11</volume><number>7</number><pages>853-860</pages><co_aut>et al.</co_aut></literature><literature><id>1427</id><title>Hyperekplexia: a treatable neurogenetic disease</title><author>Zhou L</author><journal>Brain Dev</journal><year>2002</year><book /><volume>24</volume><number>7</number><pages>669-674</pages><co_aut>et al.</co_aut></literature><literature><id>1428</id><title>Major and minor form of hereditary hyperekplexia</title><author>Tijssen MA</author><journal>Mov Disord</journal><year>2002</year><book /><volume>17</volume><number>4</number><pages>826-830</pages><co_aut>et al.</co_aut></literature><literature><id>1429</id><title>Successful treatment of severe infantile hyperekplexia with low-dose clobazam</title><author>Stewart WA</author><journal>J Child Neurol</journal><year>2002</year><book /><volume>17</volume><number>2</number><pages>154-156</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>